Gilead Signs Deals With Indian Companies for Low-Cost Generic HIV Drug

by Kathy Jones on  August 3, 2012 at 8:59 PM Corporate News
RSS Email Print This Page Comment bookmark
Font : A-A+

American drug giant Gilead Sciences has announced that it has signed deals with three Indian pharmaceutical companies to manufacture low-cost generic versions of its HIV drug emtricitabine in developing countries.
 Gilead Signs Deals With Indian Companies for Low-Cost Generic HIV Drug
Gilead Signs Deals With Indian Companies for Low-Cost Generic HIV Drug

Gilead said that it has signed deals with Ranbaxy Laboratories, Strides Arcolab and Mylan Inc to manufacture the drug in their Indian units and added that it will be providing funding and technology in order to reduce the manufacturing costs.

Announcing the deals, Gilead CEO John C Martin said, "On-going collaboration (with Indian companies) will be critical for furthering access to affordable, high-quality, first-line HIV treatment for developing countries."

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Oral Health And AIDS Drug Toxicity AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...